232 related articles for article (PubMed ID: 27628190)
1. Cytogenetics in the management of chronic lymphocytic leukemia: an update by the Groupe francophone de cytogénétique hématologique (GFCH).
Nguyen-Khac F; Borie C; Callet-Bauchu E; Eclache V; Struski S
Ann Biol Clin (Paris); 2016 Oct; 74(5):561-567. PubMed ID: 27628190
[TBL] [Abstract][Full Text] [Related]
2. Cytogenetics in the management of "chronic myeloid leukemia": an update by the Groupe francophone de cytogénétique hématologique (GFCH).
Roche-Lestienne C; Boudry-Labis E; Mozziconacci MJ
Ann Biol Clin (Paris); 2016 Oct; 74(5):511-515. PubMed ID: 27477825
[TBL] [Abstract][Full Text] [Related]
3. Cytogenetics in the management of acute myeloid leukemia: an update by the Groupe francophone de cytogénétique hématologique (GFCH).
Luquet I; Bidet A; Cuccuini W; Lafage-Pochitaloff M; Mozziconacci MJ; Terré C
Ann Biol Clin (Paris); 2016 Oct; 74(5):535-546. PubMed ID: 27545007
[TBL] [Abstract][Full Text] [Related]
4. Cytogenetics in the management of hematologic malignancies: an update by the Groupe francophone de cytogénétique hématologique (GFCH).
Nguyen-Khac F; Daudignon A; Eclache V; Lafage-Pochitaloff M; Lefebvre C; Luquet I; Penther D
Ann Biol Clin (Paris); 2016 Oct; 74(5):509-510. PubMed ID: 27465598
[TBL] [Abstract][Full Text] [Related]
5. Cytogenetics in the management of chronic lymphocytic leukemia: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
Nguyen-Khac F; Balogh Z; Chauzeix J; Veronese L; Chapiro E
Curr Res Transl Med; 2023; 71(4):103410. PubMed ID: 38039634
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetics in the management of multiple myeloma: an update by the Groupe francophone de cytogénétique hématologique (GFCH).
Daudignon A; Quilichini B; Ameye G; Poirel H; Bastard C; Terré C
Ann Biol Clin (Paris); 2016 Oct; 74(5):588-595. PubMed ID: 27707673
[TBL] [Abstract][Full Text] [Related]
7. Cytogenetics in the management of children and adult acute lymphoblastic leukemia (ALL): an update by the Groupe francophone de cytogénétique hématologique (GFCH).
Baranger L; Cuccuini W; Lefebvre C; Luquet I; Perot C; Radford I; Lafage-Pochitaloff M
Ann Biol Clin (Paris); 2016 Oct; 74(5):547-560. PubMed ID: 27707671
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetics in the management of Philadelphia-negative myeloproliferative neoplasms: an update by the Groupe francophone de cytogénétique hématologique (GFCH).
Bilhou-Nabéra C; Bidet A; Eclache V; Lippert E; Mozziconacci MJ
Ann Biol Clin (Paris); 2016 Oct; 74(5):517-523. PubMed ID: 27477946
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetic place in managing myelodysplastic syndromes: an update by the Groupe francophone de cytogénétique hématologique (GFCH).
Eclache V; Lafage-Pochitaloff M; Lefebvre C; Penther D; Raynaud S; Tigaud I
Ann Biol Clin (Paris); 2016 Oct; 74(5):525-534. PubMed ID: 27546835
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetics in the management of lymphomas and lymphoproliferative disorders in adults and children: an update by the Groupe francophone de cytogénétique hématologique (GFCH).
Lefebvre C; Callet-Bauchu E; Chapiro E; Nadal N; Penther D; Poirel HA
Ann Biol Clin (Paris); 2016 Oct; 74(5):568-587. PubMed ID: 27707672
[TBL] [Abstract][Full Text] [Related]
11. The complex karyotype in hematological malignancies: a comprehensive overview by the Francophone Group of Hematological Cytogenetics (GFCH).
Nguyen-Khac F; Bidet A; Daudignon A; Lafage-Pochitaloff M; Ameye G; Bilhou-Nabéra C; Chapiro E; Collonge-Rame MA; Cuccuini W; Douet-Guilbert N; Eclache V; Luquet I; Michaux L; Nadal N; Penther D; Quilichini B; Terre C; Lefebvre C; Troadec MB; Véronèse L
Leukemia; 2022 Jun; 36(6):1451-1466. PubMed ID: 35430613
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic and molecular cytogenetic analysis of B cell chronic lymphocytic leukemia: specific chromosome aberrations identify prognostic subgroups of patients and point to loci of candidate genes.
Döhner H; Stilgenbauer S; Fischer K; Bentz M; Lichter P
Leukemia; 1997 Apr; 11 Suppl 2():S19-24. PubMed ID: 9178833
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetics in the management of multiple Myeloma: The guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
Daudignon A; Cuccuini W; Bracquemart C; Godon C; Quilichini B; Penther D
Curr Res Transl Med; 2023; 71(4):103427. PubMed ID: 38035476
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetics in the management of B-cell acute lymphoblastic leukemia: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
Tueur G; Quessada J; De Bie J; Cuccuini W; Toujani S; Lefebvre C; Luquet I; Michaux L; Lafage-Pochitaloff M
Curr Res Transl Med; 2023; 71(4):103434. PubMed ID: 38064905
[TBL] [Abstract][Full Text] [Related]
15. Cytogenetics in the management of myelodysplastic neoplasms (myelodysplastic syndromes, MDS): Guidelines from the groupe francophone de cytogénétique hématologique (GFCH).
Auger N; Douet-Guilbert N; Quessada J; Theisen O; Lafage-Pochitaloff M; Troadec MB
Curr Res Transl Med; 2023; 71(4):103409. PubMed ID: 38091642
[TBL] [Abstract][Full Text] [Related]
16. Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities.
Mittal AK; Hegde GV; Aoun P; Bociek RG; Dave BJ; Joshi AD; Sanger WG; Weisenburger DD; Joshi SS
Int J Mol Med; 2007 Oct; 20(4):461-9. PubMed ID: 17786276
[TBL] [Abstract][Full Text] [Related]
17. Genetics of chronic lymphocytic leukemia: genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course.
Stilgenbauer S; Bullinger L; Lichter P; Döhner H;
Leukemia; 2002 Jun; 16(6):993-1007. PubMed ID: 12040431
[TBL] [Abstract][Full Text] [Related]
18. Genomic aberrations and survival in chronic lymphocytic leukemia.
Döhner H; Stilgenbauer S; Benner A; Leupolt E; Kröber A; Bullinger L; Döhner K; Bentz M; Lichter P
N Engl J Med; 2000 Dec; 343(26):1910-6. PubMed ID: 11136261
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetics in the management of T-cell acute lymphoblastic leukemia (T-ALL): Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
De Bie J; Quessada J; Tueur G; Lefebvre C; Luquet I; Toujani S; Cuccuini W; Lafage-Pochitaloff M; Michaux L
Curr Res Transl Med; 2023; 71(4):103431. PubMed ID: 38016418
[TBL] [Abstract][Full Text] [Related]
20. The importance of complex karyotype in prognostication and treatment of chronic lymphocytic leukemia (CLL): a comprehensive review of the literature.
Jarošová M; Plevová K; Kotašková J; Doubek M; Pospíšilová Š
Leuk Lymphoma; 2019 Oct; 60(10):2348-2355. PubMed ID: 30773964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
